Amicus Therapeutics, Inc. (FOLD) Reports Q1 EPS Loss of $0.39

May 4, 2011 4:46 PM EDT Send to a Friend

Amicus Therapeutics, Inc. (NASDAQ: FOLD) reported Q1 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Amicus Therapeutics, Inc. (FOLD) Reports Q1 EPS Loss of $0.39

Member Login

Free News Feed